BIOXYTRAN, INC. Reports Director Changes and Officer Compensation

Ticker: BIXT · Form: 8-K · Filed: Dec 15, 2025 · CIK: 1445815

Bioxytran, Inc 8-K Filing Summary
FieldDetail
CompanyBioxytran, Inc (BIXT)
Form Type8-K
Filed DateDec 15, 2025
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.001 B
Sentimentneutral

Sentiment: neutral

Topics: director-change, officer-compensation, corporate-governance

TL;DR

BIOXYTRAN board shakeup, new director elected, officer pay details disclosed.

AI Summary

On December 7, 2025, BIOXYTRAN, INC. filed an 8-K report detailing the departure of a director and the election of a new director. The filing also addresses compensatory arrangements for certain officers. The company, formerly known as U.S. Rare Earth Minerals, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Director departures and changes in officer compensation can indicate internal shifts or challenges within the company.

Key Players & Entities

  • BIOXYTRAN, INC. (company) — Registrant
  • U.S. Rare Earth Minerals, Inc. (company) — Former company name
  • Nevada (jurisdiction) — State of Incorporation
  • December 7, 2025 (date) — Date of earliest event reported

FAQ

Who is the departing director and who is the newly elected director?

The filing indicates the departure of a director and the election of a new director, but their specific names are not provided in the provided text.

What specific compensatory arrangements for officers are detailed in this filing?

The filing mentions compensatory arrangements of certain officers but does not provide specific details within the provided text.

What was BIOXYTRAN, INC. previously named?

BIOXYTRAN, INC. was formerly known as U.S. Rare Earth Minerals, Inc., and prior to that, U.S. Natural Nutrients & Minerals, Inc.

In which state is BIOXYTRAN, INC. incorporated?

BIOXYTRAN, INC. is incorporated in Nevada.

What is the SIC code for BIOXYTRAN, INC.?

The Standard Industrial Classification (SIC) code for BIOXYTRAN, INC. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 611 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-12-15 06:15:32

Key Financial Figures

  • $0.001 B — ch registered Common Stock, par value $0.001 BIXT OTCQB Indicate by check mark whe

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOXYTRAN, INC. By: /s/ David Platt, Ph.D. David Platt, Ph.D., its Chief Executive Officer Date December 15, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.